Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial.
Gibson GE, Luchsinger JA, Cirio R, Chen H, Franchino-Elder J, Hirsch JA, Bettendorff L, Chen Z, Flowers SA, Gerber LM, Grandville T, Schupf N, Xu H, Stern Y, Habeck C, Jordan B, Fonzetti P.
Gibson GE, et al. Among authors: habeck c.
J Alzheimers Dis. 2020;78(3):989-1010. doi: 10.3233/JAD-200896.
J Alzheimers Dis. 2020.
PMID: 33074237
Free PMC article.
Clinical Trial.